Increased Vitamin B12 levels are associated with mortality in critically ill medical patients

Clinical Nutrition

Volumn 31, Issue 1, 2012, Pages 53-59

  Sviri, S ^a   Khalaila, R ^a   Daher, S ^a   Bayya, A ^a   Linton, D M ^a   Stav, I ^a   van Heerden, P V ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

ICU; Mortality; Outcome; Vitamin B12

Indexed keywords

CYANOCOBALAMIN;

ADULT; AGED; APACHE; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE ASSOCIATION; FEMALE; HUMAN; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PROGNOSIS; SEX DIFFERENCE; SURVIVAL RATE; UPREGULATION; VITAMIN BLOOD LEVEL;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; AGED, 80 AND OVER; CRITICAL ILLNESS; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; ISRAEL; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VITAMIN B 12;

EID: 84856235911     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2011.08.010     Document Type: Article

References (31)

1. Manzanares W., Hardy G. Vitamin B12: the forgotten micronutrient for critical care. Curr Opin Clin Nutr Metab Care 2010, 13(6):662-668.
2. Puntambekar P., Basha M.M., Zak I.T., Madhavan R. Rare sensory and autonomic disturbances associated with vitamin B12 deficiency. JNeurol Sci 2009, 287(1-2):285-287.
3. Smith A.D., Refsum H. Vitamin B-12 and cognition in the elderly. Am J Clin Nutr 2009, 89(2):707S-711S.
4. Andres E., Fothergill H., Mecili M. Efficacy of oral cobalamin (vitamin B12) therapy. Expert Opin Pharmacother 2010, 11(2):249-256.
5. Albert C.M., Cook N.R., Gaziano J.M., Zaharris E., MacFadyen J., Danielson E., et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. Jama 2008, 299(17):2027-2036.
6. Ebbing M., Bleie O., Ueland P.M., Nordrehaug J.E., Nilsen D.W., Vollset S.E., et al. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. Jama 2008, 300(7):795-804.
7. Zhang S.M., Cook N.R., Albert C.M., Gaziano J.M., Buring J.E., Manson J.E. Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. Jama 2008, 300(17):2012-2021.
8. Vizzardi E., Bonadei I., Zanini G., Frattini S., Fiorina C., Raddino R., et al. Homocysteine and heart failure: an overview. Recent Pat Cardiovasc Drug Discov 2009, 4(1):15-21.
9. Chiche L., Jean R., Romain F., Roux F., Thomas G., Canavese S., et al. Clinical implications of high cobalamin blood levels for internal medicine. Rev Med Interne 2008, 29(3):187-194.
10. Ermens A.A., Vlasveld L.T., Lindemans J. Significance of elevated cobalamin (vitamin B12) levels in blood. Clin Biochem 2003, 36(8):585-590.
11. Salles N., Herrmann F., Sakbani K., Rapin C.H., Sieber C. High vitamin B12 level: a strong predictor of mortality in elderly inpatients. JAm Geriatr Soc 2005, 53(5):917-918.
12. Gimsing P., Hippe E. Increased concentration of transcobalamin I in a patient with metastatic carcinoma of the breast. Scand J Haematol 1978, 21(3):243-249.
13. Heinz J., Kropf S., Domrose U., Westphal S., Borucki K., Luley C., et al. Bvitamins and the risk of total mortality and cardiovascular disease in end-stage renaldisease: results of a randomized controlled trial. Circulation 2010, 121(12):1432-1438.
14. Carmel R. Extreme elevation of serum transcobalamin I in patients with metastatic cancer. NEngl J Med 1975, 292(6):282-284.
15. Nexo E., Olesen H., Norredam K., Schwartz M. Arare case of megaloblastic anaemia caused by disturbances in the plasma cobalamin binding proteins in a patient with hepatocellular carcinoma. Scand J Haematol 1975, 14(5):320-327.
16. Carmel R., Tatsis B., Baril L. Circulating antibody to transcobalamin II causing retention of vitamin B12 in the blood. Blood 1977, 49(6):987-1000.
17. Reynolds E.H., Bottiglieri T., Laundy M., Stern J., Payan J., Linnell J., et al. Subacute combined degeneration with high serum vitamin B12 level and abnormal vitamin B12 binding protein. New cause of an old syndrome. Arch Neurol 1993, 50(7):739-742.
18. Corcoran T.B., O'Neill M.P., Webb S.A., Ho K.M. Inflammation, vitamin deficiencies and organ failure in critically ill patients. Anaesth Intensive Care 2009, 37(5):740-747.
19. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13(10):818-829.
20. Brunello A.G., Haenggi M., Wigger O., Porta F., Takala J., Jakob S.M. Usefulness of a clinical diagnosis of ICU-acquired paresis to predict outcome in patients with SIRS and acute respiratory failure. Intensive Care Med 2010, 36(1):66-74.
21. Faisy C., Lerolle N., Dachraoui F., Savard J.F., Abboud I., Tadie J.M., et al. Impact of energy deficit calculated by a predictive method on outcome in medical patients requiring prolonged acute mechanical ventilation. Br J Nutr 2009, 101(7):1079-1087.
22. Hampshire P.A., Welch C.A., McCrossan L.A., Francis K., Harrison D.A. Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database. Crit Care 2009, 13(4):R137.
23. Sprung C.L., Ledoux D., Bulow H.H., Lippert A., Wennberg E., Baras M., et al. Relieving suffering or intentionally hastening death: where do you draw the line?. Crit Care Med 2008, 36(1):8-13.
24. Sprung C.L., Woodcock T., Sjokvist P., Ricou B., Bulow H.H., Lippert A., et al. Reasons, considerations, difficulties and documentation of end-of-life decisions in European intensive care units: the ETHICUS Study. Intensive Care Med 2008, 34(2):271-277.
25. Ganz F.D., Benbenishty J., Hersch M., Fischer A., Gurman G., Sprung C.L. The impact of regional culture on intensive care end of life decision making: an Israeli perspective from the ETHICUS study. JMed Ethics 2006, 32(4):196-199.
26. Gortzis L.G., Sakellaropoulos F., Ilias I., Stamoulis K., Dimopoulou I. Predicting ICU survival: a meta-level approach. BMC Health Serv Res 2008, 8:157.
27. Karlsson S., Ruokonen E., Varpula T., Ala-Kokko T.I., Pettila V. Long-term outcome and quality-adjusted life years after severe sepsis. Crit Care Med 2009, 37(4):1268-1274.
28. Linko R., Suojaranta-Ylinen R., Karlsson S., Ruokonen E., Varpula T., Pettila V. One-year mortality, quality of life and predicted life-time cost-utility in critically ill patients with acute respiratory failure. Crit Care 2010, 14(2):R60.
29. Veber D., Mutti E., Tacchini L., Gammella E., Tredici G., Scalabrino G. Indirect down-regulation of nuclear NF-kappaB levels by cobalamin in the spinal cord and liver of the rat. JNeurosci Res 2008, 86(6):1380-1387.
30. Schindler K., Zauner C., Buchmayer H., Fodinger M., Wolfl G., Bieglmayer C., et al. High prevalence of hyperhomocysteinemia in critically ill patients. Crit Care Med 2000, 28(4):991-995.
31. Thomson A.B., Sauve M.D., Kassam N., Kamitakahara H. Safety of the long-term use of proton pump inhibitors. World J Gastroenterol 2010, 16(19):2323-2330.